Gazette M Tablet is a combination of Gliclazide and Metformin, stands as a valuable treatment for individuals diagnosed with type 2 diabetes.

Gazette M Tablet medication combines the mechanisms of Gliclazide and Metformin Gliclazide enhances insulin release by selectively binding to sulfonylurea receptors, facilitating better blood sugar control. Simultaneously, Metformin works by reducing glucose production in the liver and improving the body's response to insulin.

The recommended dosage may vary based on individual health conditions, and it's crucial to adhere to the specific instructions for optimal results.

Certain side effects can include hypoglycemia, gastrointestinal discomfort, and other adverse reactions.

It is contraindicated in individuals with specific medical conditions, and regular monitoring of blood sugar levels is advised, especially during stressful situations. Pregnant or lactating individuals should consult their healthcare provider before using this medication.

In the event of a missed dose, it is advisable to take at the earliest opportunity However, if the next scheduled dose is imminent, skipping the missed dose is recommended to avoid doubling up